Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pamela Esposito currently holds 6,068 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pamela Esposito has been a net seller of KYMR stock. They have purchased $0 and sold $11.7M worth of shares.
Pamela Esposito's most recent insider trade was on Jun 24, 2026, when they sold 6,068 shares at $0.00 per share.
Pamela Esposito serves as Executive at Kymera Therapeutics, Inc. (KYMR). They have executed 69 insider transactions totaling $11.7M over their tenure at the company.
Pamela Esposito holds the position of Executive at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Pamela Esposito has shown a selling trading pattern, with $0 in total purchases and $11.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pamela Esposito was on Dec 17, 2025, when they sold $1.2M worth of KYMR shares. This transaction involved 14,505 shares at $81.56 per share.
Pamela Esposito currently owns 6,068 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pamela Esposito's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pamela Esposito has 69 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Pamela Esposito and 40,000+ other insiders.